Andrew Ross Camden

UMAC President Camden sells 100,000 shares (28.8% of holdings) for $3.0M at $30.05; stock now $26.39 after 90-day +60.4% rally

Andrew Ross Camden, as President, executed a substantial sale of 100,000 shares at $30.05 on 2026-06-04, reducing his stake from 346,750 to 246,750 shares. The transaction occurred at a price near the 52-week high of $34.36, with the stock having surged +85.1% over the prior 30 days and +60.4% over 90 days. His single prior sale at UMAC on 2025-12-12 showed poor timing: the stock rose +114.7% in the 90 days following that sale, indicating he sold before a substantial rally. The company is operationally profitable at the quarterly level ($10.3M net income) but was unprofitable on a full-year basis, creating ambiguity about underlying financial momentum. The current price of $26.39 is -23.2% from the 52-week high, suggesting the stock's recent gains have moderated since this transaction.

COO Camden Andrew Ross sold 50,000 shares (50.0K) of UMAC at $10.32, reducing stake by 16.3% to 256,000 shares.

Camden Andrew Ross, the Chief Operating Officer, sold 50,000 shares (50.0K shares) on 2025-12-12 at $10.32, a sale that reduced his holdings by 16.3% from 306,000 to 256,000 shares. The stock currently trades at $9.09, down 52.9% from its 52-week high of $19.31 and down 21.9% over the past 90 days, indicating significant downward momentum. Most notably, the company was unprofitable over its most recent full fiscal year despite reporting a net income of $1,603,465.00 in the latest quarter, suggesting operational volatility or seasonal results that mask underlying challenges. The transaction price of $10.32 sits above the current $9.09, meaning the sale occurred before the stock's recent further decline, though still well below the 52-week high the stock had previously reached.